Not for commercial use – Ericsson Inc.
"* /0
2%<"*?Briefly, there is not enough evidence to know for sure, either way;
however, research efforts are on-going. The existing scientific
evidence is conflicting and many of the studies that have been done
to date have suffered from flaws in their research methods. Animal
experiments investigating the effects of RF exposures cha racteristic
of mobile phones have yielded conflicting results.
A few animal studies, however, have suggested that low levels of RF
could accelerate the development of cancer in laboratory anima ls. In
one study, mice genetically altered to be predisposed to developing
one type of cancer developed more than twice as many such cancers
when they were exposed to RF energy compared to controls. There is
much uncertainty among scientists about whether results obtained
from animal studies apply to the use of mobile phones. First, it is
uncertain how to apply the results obtained in rats and mice to
humans. Second, many of the studies that showed increased tumor
development used animals that had already been treated with cancer-
causing chemicals, and other studies exposed the animals to the RF
virtually continuously – up to 22 hours per day.
For the past five years in the United States, the mobile phone
industry has supported research into the safety of mobile phones .
This research has resulted in two findings in particular that merit
additional study:
1 In a hospital-based, case-control study, researchers looked for an
association between mobile phone use and either glioma (a type of
brain cancer) or acoustic neuroma (a benign tumor of the nerve
sheath). No statistically significant association was found between
mobile phone use and acoustic neuroma. There was also no
association between mobile phone use and gliomas when all types
of types of gliomas were considered together.
It should be noted that the average length of mobile phone
exposure in this study was less than three years.
When 20types of g lioma were considered separately, however, an
association was found between mobile phone use and one rare
type of glioma, neuroepithelliomatous tumors. It is possible with
multiple comparisons of the same sample that this association
occurred by chance. Moreover, the risk did not increase with how
often the mobile phone was used, or the length of the call s. In fact,
the risk actually decreased with cumulative hours of mobile phone
use. Most cancer causing agents increase risk with increased
exposure. An ongoing study of brain cancers by the National
Cancer Institute is expected to bear on the accuracy and
repeatability of these results.1
2 Researchers conducted a large battery of laboratory tests to assess
the effects of exposure to mobile phone RF on genetic material.
These included tests for several kinds of abnormalities, including
mutations, chromosomal aberrations, DNA strand breaks, and
structural changes in the genetic material of blood cells called
lymphocytes. None of the tests showed any effect of the RF except
for the micronucleus assay, which detects structural effects on the
genetic material. The cells in this assay showed changes after
exposure to simulated cell phone radiation, but only after
24hours of exposure. It is possible that exposing the test cells to
radiation for this long resulted in heating. Since this assay is
known to be sensitive to heating, heat alone could have caused the
abnormalities to occur. The data already in the literature on the
response of the micronucleus assay to RF are conflicting. Thus,
follow-up research is necessary.2
FDA is currently working with government, industry, and
academic groups to ensure the proper follow-up to these industry-
funded research findings. Collaboration with the Cellular